Emory Team Uncovers Small Molecule that Boosts RNAi Silencing; Effigene to Sell Tech
Thursday, July 24th, 2008By Doug Macron
A research team led by investigators from Emory University this week published data showing how a novel cell-based assay technology, licensed to startup Effigene Pharmaceuticals, was able to identify a small molecule that could enhance siRNA-mediated mRNA degradation and endogenous microRNA biogenesis. (more…)